GLP-1 receptor agonists combined with metformin most effectively reduce weight and BMI in PCOS
GLP-1 Combined With Metformin Shows Weight Loss For PCOS
This network meta-analysis evaluated GLP-1 receptor agonists, metformin, and myoinositol for managing polycystic ovary syndrome. The study f…
A combination of GLP-1 receptor agonists and metformin may be more effective for weight loss in women with polycystic ovary syndrome than ot…
Initial dual oral therapy improves HbA1c target achievement in early stage type 2 diabetes
Dual Therapy Shows Better Results for Type 2 Diabetes Control
Researchers evaluated the efficacy of initial dual oral therapy compared to monotherapy for patients with early-stage type 2 diabetes. The f…
Starting with two medications instead of one may help people with early type 2 diabetes reach their blood sugar goals more effectively.
General medical management improves medication adherence and lifestyle outcomes in older adults with type 2 diabetes
New management model improves medication use and health for seniors
This randomized controlled trial of 200 older adults with type 2 diabetes and atherosclerotic cardiovascular disease found that a general me…
A new personalized care plan helps older adults with diabetes and heart disease stay on their medications and improve their daily habits.
Diabetes mellitus acts as a context-dependent modifier of risk and phenotype in neurological disorders
Diabetes May Influence Risk and Progress of Neurological Disorders
This narrative review synthesizes evidence regarding the role of diabetes mellitus (DM) as a disease modifier across various neurological co…
New research suggests that diabetes can change how certain neurological conditions progress, potentially opening doors for new treatment opt…
Transporter gene variants in SLC and SLC47 families impact metformin pharmacokinetics and pharmacodynamics
Genetic variations in transporter genes affect how metformin treats diabetes
This narrative review synthesizes 63 studies regarding the association between twelve single nucleotide variants (SNVs) in seven transporter…
Specific genetic markers in transport genes may explain why some people respond better to metformin than others.
Metformin is associated with higher lactate concentrations during exercise in adults with prediabetes and type 2 diabetes
Metformin May Raise Lactate During Exercise
This meta-analysis of 325 participants evaluated the impact of metformin on exercise metabolism and capacity. The analysis found that metfor…
A new analysis suggests metformin may increase lactate levels during exercise, which could affect workout intensity.
GLP-1 agonists show short-term metabolic benefit in PCOS but reproductive effects remain uncertain
Doctors suggest GLP-1 drugs help weight but need careful planning before pregnancy in PCOS
A meta-analysis of GLP-1 receptor agonists in PCOS found relatively robust support for short-term metabolic benefit, but reproductive outcom…
New analysis shows GLP-1 drugs help with weight loss for PCOS patients. However, doctors are unsure if these drugs improve fertility and nee…
Sitagliptin and liraglutide superior for CGM targets in type 2 diabetes
Two diabetes drugs outperform others in long-term glucose control
This randomized trial compared adding sitagliptin, liraglutide, glimepiride, or insulin glargine to metformin in 1,080 participants with typ…
A five-year trial shows sitagliptin and liraglutide offer better glucose stability and safety than glimepiride or insulin glargine for peopl…
Metformin use linked to modest glaucoma risk reduction in diabetic patients
Metformin use linked to lower glaucoma risk in people with diabetes
A large meta-analysis of diabetic patients found metformin use associated with a modest reduction in glaucoma incidence, though evidence cer…
A massive review of over 1.2 million patients suggests metformin might lower the chance of developing glaucoma compared to other diabetes dr…
Metformin shows limited impact on gonadotropin levels in PCOS women
Metformin changes one hormone ratio but leaves others unchanged in PCOS
A meta-analysis of 51 RCTs finds metformin does not alter FSH or LH but significantly increases the LH/FSH ratio in women with PCOS.
Metformin treatment significantly increased the LH to FSH ratio in women with PCOS, while leaving FSH and LH levels alone.
Paternal metformin use during spermatogenesis shows no increased risk for major congenital malformations in over 11 000 children across five countries
New analysis shows fathers taking metformin did not raise birth defect risks for their children
A large meta-analysis involving more than 11 000 live-born children found no association between fathers taking metformin and birth defects.…
A large study of over 11,000 children found no higher risk of birth defects when dads took metformin before conception. This good news appli…
Triple oral therapy with metformin, SGLT-2, and DPP-4 inhibitors lowers HbA1c better than dual regimens in adults with type 2 diabetes
Triple oral diabetes drugs lower blood sugar better than two-drug regimens
A systematic review and meta-analysis of 2,606 adults with type 2 diabetes found that triple oral therapy combining metformin, an SGLT-2 inh…
A large analysis shows that taking three specific oral diabetes medicines together lowers blood sugar more effectively than taking just two …